Lifshitz & Miller LLP Announces Investigation of Adient PLC, Applied Optoelectronics, Inc., Cocrystal Pharma, Inc., Microchip Technology Incorporated, MGT Capital Investments, Inc., TG Therapeutics, Inc. and USA Technologies, Inc.
NEW YORK, Oct. 30, 2018 /PRNewswire/ --
Adient PLC (ADNT)
Lifshitz & Miller announces investigation into possible securities laws violations in connection with ADNT's CEO stepping down and decreased profit forecast for the year.
If you are an Adient investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].
Applied Optoelectronics, Inc. (AAOI)
Lifshitz & Miller announces investigation into possible securities laws violations in connection with the announcement that the Company had identified an issued with a small percentage of 25G lasers.
If you are an AAOI investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].
Cocrystal Pharma, Inc. (COCP)
Lifshitz & Miller announces investigation into possible securities laws violations in connection with allegations that former officers had engaged in "pump and dump" schemes from 2013 through 2018.
If you are a Cocrystal investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].
Microchip Technology Incorporated (MCHP)
Lifshitz & Miller announces investigation into possible securities laws violations in connection with the Company's acquisition of Microsemi Corporation.
If you are a MCHP investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].
MGT Capital Investments, Inc. (MGTI)
Lifshitz & Miller announces investigation into possible securities laws violations in connection with allegations that a former officer had engaged in "pump and dump" schemes from 2013 through 2018.
If you are an MGT investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].
TG Therapeutics, Inc. (TGTX)
Lifshitz & Miller announces investigation into possible securities laws violations in connection with the Company not proceeding with interim analysis of its Ublituximad product candidate.
If you are a TGTX investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].
USA Technologies, Inc. (USAT)
Lifshitz & Miller announces investigation into possible securities laws violations in connection with the "internal investigation of current and prior period matters relating to certain of the Company's contractual arrangements, including the accounting treatment, financial reporting and internal controls related to such arrangements."
If you are a USAT investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].
ATTORNEY ADVERTISING. © 2018 Lifshitz & Miller LLP. The law firm responsible for this advertisement is Lifshitz & Miller LLP, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Contact:
Joshua M. Lifshitz, Esq.
Lifshitz & Miller LLP
Phone: 516-493-9780
Facsimile: 516-280-7376
Email: [email protected]
SOURCE Lifshitz & Miller Law Firm
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article